IGC Pharma, Inc. (IGC)
IGC Pharma Market Cap: 27.52M for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Esperion Therapeutics, Inc. | 720.69M |
| Theravance Biopharma, Inc. | 1.014B |
| NRX Pharmaceuticals, Inc. | 67.20M |
| CEL-SCI Corp. | 15.63M |
| AIM ImmunoTech, Inc. | 3.942M |
Market Cap Related Metrics
| PS Ratio | 22.24 |
| Price to Book Value | 3.400 |
| Price | 0.2963 |
| Earnings Yield | -26.26% |